We are live on !
Find out more
MAK Capital One Portfolio holdings
AUM
$714M
Turnover
30.43%
1-Year Est. Return
68.07%
This Fund
S&P 500
This Quarter Est. Return
+38.81%
1 Year Est. Return
+68.07%
3 Year Est. Return
+199.63%
5 Year Est. Return
+307.07%
10 Year Est. Return
+2,541.72%
AUM
$714M
AUM Growth
+$35.1M
(+5.2%)
Cap. Flow
-$37.9M
Cap. Flow % of AUM
Cap. Flow %
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
82.45%
Holding
23
New
1
Increased
6
Reduced
3
Closed
6
Avg Time Held
Equity + Options
2.2
years
Top 10 Avg Time Held
Equity + Options
2.5
years
Top 20 Avg Time Held
Equity + Options
2.2
years
Avg Time Held Equity only
2.2
years
Top 10 Avg Time Held Equity only
2.5
years
Top 20 Avg Time Held Equity only
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caris Life Sciences
CAI
|
+$34.7M |
| 2 |
uniQure
QURE
|
+$20.7M |
| 3 |
Annexon
ANNX
|
+$6.29M |
| 4 |
ClearPoint Neuro
CLPT
|
+$5.93M |
| 5 |
Galicia Financial Group
GGAL
|
+$2.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Champion Homes
SKY
|
+$49.8M |
| 2 |
Coursera
COUR
|
+$32.7M |
| 3 |
Udemy
UDMY
|
+$16.9M |
| 4 |
Protalix BioTherapeutics
PLX
|
+$7.69M |
| 5 |
Comstock
LODE
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.34% |
| 2 | Technology | 17.46% |
| 3 | Financials | 16.17% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Agilysys
AGYS
$3.17B
| $125M | 17.46% |
1,192,730
| – | – |
2013 Q2
52 quarters
|
|
|
2
Galicia Financial Group
GGAL
$5.64B
| $74.3M | 10.41% |
1,485,875
+56,800
| +4% | +$2.67M |
2025 Q4
2 quarters
|
|
3
Acadia Healthcare
ACHC
$2.81B
| $71.8M | 10.07% |
2,432,962
| – | – |
2026 Q1
1 quarter
|
|
|
4
uniQure
QURE
$1.54B
| $56.7M | 7.95% |
1,232,051
+790,846
| +179% | +$20.7M |
2026 Q1
1 quarter
|
|
|
5
Champion Homes
SKY
$4.08B
| $55.7M | 7.81% |
632,374
-650,000
| -51% | -$49.8M |
2018 Q2
32 quarters
|
|
6
Autolus Therapeutics
AUTL
$423M
| $53.8M | 7.54% |
33,621,487
| – | – |
2025 Q2
4 quarters
|
|
|
7
ClearPoint Neuro
CLPT
$280M
| $42.4M | 5.94% |
2,375,861
+474,372
| +25% | +$5.93M |
2026 Q1
1 quarter
|
|
8
Grupo Supervielle
SUPV
$622M
| $41.1M | 5.75% |
4,250,000
| – | – |
2024 Q1
9 quarters
|
|
|
9
Caris Life Sciences
CAI
$8.68B
| $34.5M | 4.84% |
+1,937,229
| New | +$34.7M |
2026 Q2
0 quarters
|
|
|
10
Annexon
ANNX
$760M
| $33.5M | 4.69% |
5,862,180
+1,138,137
| +24% | +$6.29M |
2025 Q4
2 quarters
|
|
11
Standard BioTools
LAB
$253M
| $23.7M | 3.32% |
28,813,904
+2,641,278
| +10% | +$2.5M |
2025 Q1
5 quarters
|
|
|
12
Comstock
LODE
$133M
| $21.6M | 3.02% |
5,190,177
-573,552
| -10% | -$2.09M |
2026 Q1
1 quarter
|
|
13
CryoPort
CYRX
$860M
| $20.1M | 2.81% |
1,277,359
-145,906
| -10% | -$1.87M |
2025 Q3
3 quarters
|
|
14
The Honest Company
HNST
$533M
| $17.5M | 2.45% |
4,776,088
| – | – |
2025 Q4
2 quarters
|
|
15
Cenovus Energy
CVE
$61.3B
| $16.2M | 2.27% |
536,832
| – | – |
2025 Q4
2 quarters
|
|
16
Perma-Fix Environmental Services
PESI
$256M
| $14.8M | 2.07% |
1,032,958
+114,285
| +12% | +$1.27M |
2025 Q2
4 quarters
|
|
17
Yatra Online
YTRA
$61.1M
| $11.5M | 1.61% |
12,170,301
| – | – |
2018 Q3
31 quarters
|
|
|
18
Coursera
COUR
$1.32B
| – | – |
-5,618,749
| Closed | -$32.7M | – |
|
19
Fiverr
FVRR
$309M
| – | – |
-80,479
| Closed | -$806K | – |
|
|
20
Protalix BioTherapeutics
PLX
$206M
| – | – |
-3,544,139
| Closed | -$7.69M | – |
|
21
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| – | – |
-561,538
| Closed | -$139K | – |
|
|
22
PUT
Champion Homes
SKY
$4.08B
| – | – |
-1,000,000
| Closed | -$74.4M | – |
|
|
23
DELISTED
Udemy
UDMY
| – | – |
-3,658,520
| Closed | -$16.9M | – |
|
Similar funds
TC
SSCM
MAK Capital One's Q2 2026 Portfolio in Review
As of Q2 2026, MAK Capital One held 23 positions worth $714M, up 5.2% from $679M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
MAK Capital One withdrew a net $37.9M in Q2 2026, closing 6 positions and reducing 3 holdings. Its most notable exit was Coursera, an estimated $32.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
Against the trend, MAK Capital One opened a new position in Caris Life Sciences worth $34.5M.
- MAK Capital One's largest Q2 2026 buy was Caris Life Sciences: 1,937,229 shares worth $34.5M.
- MAK Capital One added most to uniQure in Q2 2026, an estimated $20.7M increase.
- MAK Capital One's biggest Q2 2026 reduction was Champion Homes, cutting an estimated $49.8M.
- MAK Capital One fully exited Coursera in Q2 2026, selling an estimated $32.7M.
- MAK Capital One's ten largest holdings make up 82% of its $714M portfolio in Q2 2026.
- MAK Capital One opened 1 new position and closed 6 in Q2 2026.
- MAK Capital One's portfolio value rose 5.2% quarter-over-quarter to $714M.
Based on MAK Capital One's 13F filing for Q2 2026, filed 14 Aug 2026.